122 related articles for article (PubMed ID: 8835917)
1. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment.
Kamijo M; Merry AC; Akdas G; Cherian PV; Sima AA
J Diabetes Complications; 1996; 10(4):183-91. PubMed ID: 8835917
[TBL] [Abstract][Full Text] [Related]
2. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy.
Kamijo M; Basso M; Cherian PV; Hohman TC; Sima AA
Diabetes Res Clin Pract; 1994 Sep; 25(2):117-29. PubMed ID: 7821191
[TBL] [Abstract][Full Text] [Related]
3. Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway.
Love A; Cotter MA; Cameron NE
Brain Res; 1995 Dec; 703(1-2):105-10. PubMed ID: 8719622
[TBL] [Abstract][Full Text] [Related]
4. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.
Cherian PV; Kamijo M; Angelides KJ; Sima AA
J Diabetes Complications; 1996; 10(4):192-200. PubMed ID: 8835918
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase deficiency improves Wallerian degeneration and nerve regeneration in diabetic thy1-YFP mice.
Chen YS; Chung SS; Chung SK
J Neuropathol Exp Neurol; 2010 Mar; 69(3):294-305. PubMed ID: 20142761
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
[TBL] [Abstract][Full Text] [Related]
7. Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats.
Yasuda H; Terada M; Taniguchi Y; Sasaki T; Maeda K; Haneda M; Kashiwagi A; Kikkawa R
Neuroreport; 1999 Aug; 10(11):2405-9. PubMed ID: 10439472
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
[TBL] [Abstract][Full Text] [Related]
10. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats.
Sato D; Kusunoki M; Shinzawa G; Feng Z; Nishina A; Nakamura T
Auton Neurosci; 2015 Dec; 193():69-73. PubMed ID: 26272532
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats.
Kato N; Mizuno K; Matsubara A; Nakano K; Kurono M; Yagihashi S
J Diabetes Complications; 1994; 8(1):27-32. PubMed ID: 8167384
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
[TBL] [Abstract][Full Text] [Related]
13. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
14. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
[TBL] [Abstract][Full Text] [Related]
16. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
18. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.
Kamijo M; Cherian PV; Sima AA
Diabetologia; 1993 Oct; 36(10):893-8. PubMed ID: 8243866
[TBL] [Abstract][Full Text] [Related]
19. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats.
Sasaki H; Naka K; Kishi Y; Furuta M; Sanke T; Mukoyama M; Nanjo K
Exp Neurol; 1997 Aug; 146(2):466-70. PubMed ID: 9270057
[TBL] [Abstract][Full Text] [Related]
20. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats.
Uehara K; Sugimoto K; Wada R; Yoshikawa T; Marukawa K; Yasuda Y; Kimura Y; Yagihashi S
J Diabetes Complications; 1997; 11(3):194-202. PubMed ID: 9174902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
